Answer
As a precaution, vedolizumab should preferably be avoided during pregnancy unless the benefits clearly outweigh any potential risk to both the mother and foetus.
Sources for this answer
- Entyvio 300 mg powder for concentrate for solution for infusionTakeda UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 17Document updated
Sources checked